Rituximab Reference vs Biosimilar Utilization for Oncology v

Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.

Related Keywords

United States , Kesselheim , Rheinland Pfalz , Germany , Canada , Canadian , Rituximab Rituxan , Bonniea Labdi , J Health Syst Pharm , Long Island University Pharmacy , Margolis Center , Duke University , Association For Accessible Medicines , Craneware Group , International Statistical Classification Of Diseases , Life Sciences , Trisus Medication Compare , International Statistical Classification , Tenth Revision , Appendix Table , Quarterly Utilization , Biosimilar Product , Deerfield Beach , Health Policy , Updated April , Manag Care Spec , Rituximab , Biosimilar , Oncology , Utilization ,